Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
International Journal of Urban and Regional Research
|
April 24, 2012
Shrinking cities: urban challenges of globalization
Cristina Martinez-Fernandez, Ivonne Audirac, Sylvie Fol, et al.
Genes
|
April 30, 2021
Accurate Quantification of AAV Vector Genomes by Quantitative PCR
Cristina Martinez-Fernandez de la Camara, Michelle E McClements, Robert E MacLaren
Expert Opinion on Emerging Drugs
|
December 23, 2022
Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa
Cristina Martinez-Fernandez de la Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
Expert Opinion on Biological Therapy
|
October 16, 2019
RPGR gene therapy presents challenges in cloning the coding sequence
Cristina Martinez-Fernandez De La Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
Human Gene Therapy. Clinical Development
|
March 20, 2019
Re: Song et al., Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice. Hum Gene Ther Clin Dev 2018; 29(4):188-197
Robert E MacLaren, M Dominik Fischer, Cristina Martinez-Fernandez De La Camara
Expert Opinion on Emerging Drugs
|
December 23, 2022
Response: 'letter to the editor: emerging gene therapy products for <i>RPGR</i>-associated X-linked retinitis pigmentosa'
Cristina Martinez-Fernandez de la Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
Genes
|
September 7, 2019
Molecular Strategies for RPGR Gene Therapy
Jasmina Cehajic Kapetanovic, Michelle E McClements, Cristina Martinez-Fernandez de la Camara, et al.
International Journal of Urban and Regional Research
|
April 24, 2012
The shrinking mining city: urban dynamics and contested territory
Cristina Martinez-Fernandez, Chung-Tong Wu, Laura K Schatz, et al.
Expert Opinion on Orphan Drugs
|
July 31, 2018
Gene therapy for the treatment of X-linked retinitis pigmentosa
Cristina Martinez-Fernandez De La Camara, Anika Nanda, Anna Paola Salvetti, et al.
Nature Communications
|
August 17, 2021
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
Harry O Orlans, Michelle E McClements, Alun R Barnard, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
International Journal of Urban and Regional Research
|
April 24, 2012
Shrinking cities: urban challenges of globalization
Cristina Martinez-Fernandez, Ivonne Audirac, Sylvie Fol, et al.
Genes
|
April 30, 2021
Accurate Quantification of AAV Vector Genomes by Quantitative PCR
Cristina Martinez-Fernandez de la Camara, Michelle E McClements, Robert E MacLaren
Expert Opinion on Emerging Drugs
|
December 23, 2022
Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa
Cristina Martinez-Fernandez de la Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
Expert Opinion on Biological Therapy
|
October 16, 2019
RPGR gene therapy presents challenges in cloning the coding sequence
Cristina Martinez-Fernandez De La Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
Human Gene Therapy. Clinical Development
|
March 20, 2019
Re: Song et al., Toxicology and Pharmacology of an AAV Vector Expressing Codon-Optimized RPGR in RPGR-Deficient Rd9 Mice. Hum Gene Ther Clin Dev 2018; 29(4):188-197
Robert E MacLaren, M Dominik Fischer, Cristina Martinez-Fernandez De La Camara
Expert Opinion on Emerging Drugs
|
December 23, 2022
Response: 'letter to the editor: emerging gene therapy products for <i>RPGR</i>-associated X-linked retinitis pigmentosa'
Cristina Martinez-Fernandez de la Camara, Jasmina Cehajic-Kapetanovic, Robert E MacLaren
Genes
|
September 7, 2019
Molecular Strategies for RPGR Gene Therapy
Jasmina Cehajic Kapetanovic, Michelle E McClements, Cristina Martinez-Fernandez de la Camara, et al.
International Journal of Urban and Regional Research
|
April 24, 2012
The shrinking mining city: urban dynamics and contested territory
Cristina Martinez-Fernandez, Chung-Tong Wu, Laura K Schatz, et al.
Expert Opinion on Orphan Drugs
|
July 31, 2018
Gene therapy for the treatment of X-linked retinitis pigmentosa
Cristina Martinez-Fernandez De La Camara, Anika Nanda, Anna Paola Salvetti, et al.
Nature Communications
|
August 17, 2021
Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
Harry O Orlans, Michelle E McClements, Alun R Barnard, et al.
Page
of 3